top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Danaher Corp (NY:DHR)

199.66 +4.88 (+2.51%)

Official Closing Price Updated: 7:00 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

29 30 Next >

Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks

March 04, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst...

Via StockStory

Topics Economy

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today ↗

February 26, 2025

Via Benzinga

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

3 Stocks Offering Strong Value and Stability

February 24, 2025

These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.

Via MarketBeat

Danaher's Options Frenzy: What You Need to Know ↗

February 21, 2025

Via Benzinga

P/E Ratio Insights for Danaher ↗

February 20, 2025

Via Benzinga

Danaher's Options Frenzy: What You Need to Know ↗

February 12, 2025

Via Benzinga

Danaher Unusual Options Activity For February 07 ↗

February 07, 2025

Via Benzinga

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook ↗

February 20, 2025

Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

February 18, 2025

Via Benzinga

Super Investors Just Bought These Stocks ↗

February 18, 2025

Every quarter, we get to see what the best of the best have bought and sold.

Via The Motley Fool

3 Healthcare Stocks Skating on Thin Ice

February 12, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...

Via StockStory

Topics Stocks

Waters Corporation Earnings: What To Look For From WAT

February 11, 2025

Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow before the bell. Here’s what to look for.

Via StockStory

Danaher's Options: A Look at What the Big Money is Thinking ↗

February 03, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

January 30, 2025

Via Benzinga

Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One' ↗

February 07, 2025

NextEra Energy posted in-line earnings for the fourth quarter and said it continues to expect adjusted EPS of $3.45-$3.70 for fiscal 2025.

Via Benzinga

Avantor Earnings: What To Look For From AVTR

February 06, 2025

Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

Earnings To Watch: Mettler-Toledo (MTD) Reports Q4 Results Tomorrow

February 05, 2025

Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect.

Via StockStory

This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

February 03, 2025

Via Benzinga

Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates

January 31, 2025

Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per...

Via StockStory

Topics Earnings

Danaher Analysts Cut Their Forecasts After Downbeat Earnings ↗

January 30, 2025

Via Benzinga

Beyond The Numbers: 5 Analysts Discuss Danaher Stock ↗

January 29, 2025

Via Benzinga

Broad-Based Sector Growth Expected For 2025 ↗

January 29, 2025

Total earnings for the 112 S&P 500 companies that have reported results are up +10.8% from the same period last year on +5.5% higher revenues, with 80.4% beating EPS estimates and 68.8% beating revenue...

Via Talk Markets

Topics Stocks Stocks / Equities

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

January 29, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.

Via Chartmill

Wednesday's session: top gainers and losers in the S&P500 index ↗

January 29, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

January 29, 2025

Curious about the S&P500 stocks that are gapping on Wednesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday? ↗

January 29, 2025

Caution dominates Wednesday's midday trading session in New York as investors anxiously await the Federal Open Market Committee decision at 2 p.m. ET.

Via Benzinga

Topics Economy Government

Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗

January 29, 2025

Pre-market stock analysis of S&P500 stocks on 2025-01-29: top gainers and losers in today's session.

Via Chartmill

Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 29, 2025

Via Benzinga

Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag ↗

January 29, 2025

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in biotechnology and life sciences.

Via Benzinga

Topics Earnings

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page